Addiction science: Uncovering neurobiological complexityEpigenetic mechanisms of drug addictionNatural rewards, neuroplasticity, and non-drug addictions(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cordCharacterisation of the human NMDA receptor subunit NR3A glycine binding siteHuman metabotropic glutamate receptor 1: mRNA distribution, chromosome localization and functional expression of two splice variantsA novel splice variant of a metabotropic glutamate receptor, human mGluR7bD2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortexMorphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in ratsHarmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expressionSerotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbensDelta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusGABAergic interneuron origin of schizophrenia pathophysiology.Leveraging the cortical cholinergic system to enhance attentionTraining your brain: Do mental and physical (MAP) training enhance cognition through the process of neurogenesis in the hippocampus?GABA A receptors: subtypes provide diversity of function and pharmacologyCannabinoid facilitation of behavioral and biochemical hedonic taste responsesA nomenclature for ligand-gated ion channelsMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in miceFunctional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptorsThe involvement of Reelin in neurodevelopmental disorders.Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersPTSD and gene variants: new pathways and new thinking.Pharmacological treatment of PTSD - established and new approachesA time-dependent role of midline thalamic nuclei in the retrieval of fear memory.Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signalingStriatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine usersNeuroprotection for ischemic stroke: past, present and futureThe metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in ratsThe anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulatorAllosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cellsThe endocannabinoid system as a target for the treatment of cannabis dependenceNeural substrates of cognitive inflexibility after chronic cocaine exposureThe spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strainThe elmiric acids: biologically active anandamide analogsActivation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.Lipid rafts, cholesterol, and the brainLooking for the role of cannabinoid receptor heteromers in striatal functionRole of lateral hypothalamic orexin neurons in reward processing and addiction
P1433
Q22251251-247DC5A1-0301-478A-8B77-12B7A8A896E9Q22251252-0AB8AC73-E529-4549-BFF3-47DBDFEB646BQ22251254-FF559802-6F63-4957-829F-02F90C53E74CQ24290799-FE499589-91BD-484C-9C42-DF44C3529284Q24298287-758F29E8-15F8-46AC-81DF-2D3271A36568Q24309996-C4C647F3-E8C7-4217-AF3D-DD29EE1D6412Q24319972-30BC7C6A-2B0B-49DE-AEE7-ADA2BF9AFAF7Q24564769-335642CF-B6F5-41C3-AE0B-C886ED95CF19Q24569565-C6DAC087-6775-4941-A4F0-72E1E492ADE0Q24595928-1965DF4C-9826-47C1-AE77-058168998096Q24596784-352C2585-00BA-45E5-802A-CF717BACC12AQ24597687-E3AE1861-4759-471D-AE2F-D40C9756044BQ24597790-17990E61-C8E3-4C60-95B5-65D0C89E1F6CQ24598925-D28E60BE-5568-41EE-B4A7-D0A7F464C977Q24598998-E3FE495F-3BE3-414B-BB60-C3B9F69C258AQ24599057-0CD22D5D-7C70-48F6-94E0-DC908DC86589Q24602175-04A232AF-F87F-43AF-A772-1ED69E6272EDQ24609005-E6C8CBA9-CFC5-4E0E-93D0-F0847CD62E90Q24620764-FD82CFF8-C234-4589-85E9-FDC84291C24BQ24630212-8F4B72DA-0699-410C-96AF-36C80ECF555EQ24630429-18A9C6AB-64E2-48C8-A6E8-EE24679BE7F7Q24632484-6964FFCA-4005-4481-8E39-A10B30E5E132Q24632936-0AE4C16E-6B6B-4EB5-9317-F10CB62AF49CQ24633134-9D957F1E-5926-4A3E-B268-8DA2A405C023Q24633256-33B7F2D0-3770-4E7A-A0F2-A282C5132AADQ24634963-2A04CD3C-9CFE-470D-8237-9658A359978BQ24644749-EFF4362B-9730-4685-BD97-C1533027FF99Q24644973-F41E9324-4692-4802-A811-3FEF2FFE3981Q24645185-981AB085-0779-4CA2-977A-42486DD18B4BQ24645270-EE48FF03-F270-4973-859E-69304C47DE03Q24646448-4F720764-7AC9-4849-AE3B-D76FC3CBD293Q24646463-03B98495-A981-4F82-B821-D63E02350842Q24648135-0CF1514E-9CB1-45BE-982E-E3CE32179643Q24648658-4219C9BB-46CC-45BB-BBF9-EA99D4EB879FQ24650104-53B46ADD-446C-4F6B-82B4-F33F2501F50CQ24650559-10CB43DB-23FE-454A-8A43-4A8452DD8E67Q24652204-EF17DC01-AC5A-4CDD-B066-ACD32527A7B9Q24655761-39D97C5D-8A2E-42B9-866B-5C88228BDCD3Q24658338-9B771DBD-8404-48E4-A4EA-0204E85E23FFQ24658346-0576AEC7-1B6F-4037-9E74-FE8D5B875E78
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Neuropharmacology
@ast
Neuropharmacology
@da
Neuropharmacology
@de
Neuropharmacology
@en
Neuropharmacology
@es
Neuropharmacology
@fi
Neuropharmacology
@fr
Neuropharmacology
@it
Neuropharmacology
@nb
Neuropharmacology
@nl
type
label
Neuropharmacology
@ast
Neuropharmacology
@da
Neuropharmacology
@de
Neuropharmacology
@en
Neuropharmacology
@es
Neuropharmacology
@fi
Neuropharmacology
@fr
Neuropharmacology
@it
Neuropharmacology
@nb
Neuropharmacology
@nl
prefLabel
Neuropharmacology
@ast
Neuropharmacology
@da
Neuropharmacology
@de
Neuropharmacology
@en
Neuropharmacology
@es
Neuropharmacology
@fi
Neuropharmacology
@fr
Neuropharmacology
@it
Neuropharmacology
@nb
Neuropharmacology
@nl
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Neuropharmacol.
P123
P1250
P1277
P1476
Neuropharmacology
@en